Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.0%)
USD 0.22
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.3 Million | -16.92 Million | -105 Thousand | -11.93 Million | -7.05 Million | -6.45 Million |
| Net Income | -19.47 Million | -25.06 Million | -24.73 Million | -19.34 Million | -12.81 Million | -7.42 Million |
| Depreciation & Amortization | - | 99 Thousand | 478 Thousand | 572 Thousand | 416.21 Thousand | 377.13 Thousand |
| Deferred income taxes | - | - | 452 Thousand | 1.6 Million | - | -309.85 Thousand |
| Stock-based compensation | 2808.00 | 5.52 Million | 3.98 Million | 3.37 Million | 2.98 Million | 692.99 Thousand |
| Change in working capital | 28 Thousand | 2.5 Million | 19.65 Million | 1.69 Million | 2.22 Million | -475.94 Thousand |
| Other non-cash items | 334 Thousand | 18 Thousand | 52 Thousand | 168 Thousand | 131.47 Thousand | 694.88 Thousand |
| Investing Cash Flow | -11.82 Million | -20.22 Million | -264 Thousand | 98 Thousand | -257.4 Thousand | -50.63 Thousand |
| Investments in PPE | -9000.00 | -9000.00 | - | -2000.00 | -157.4 Thousand | -50.63 Thousand |
| Acquisitions | 319 Thousand | -236 Thousand | - | - | - | - |
| Investment purchases | -48.43 Million | -19.97 Million | - | - | -100 Thousand | - |
| Sales/Maturities of investments | 36.29 Million | 19.97 Thousand | - | 100 Thousand | - | - |
| Other Investing Activities | -11.81 Thousand | -19.97 Thousand | -264 Thousand | -560 Thousand | -100.00 | - |
| Financing Cash Flow | 80 Thousand | -26 Thousand | 66.16 Million | 12 Million | 9.58 Million | 8751.81 |
| Debt repayment | -79 Thousand | -152 Thousand | -2.41 Million | -192 Thousand | -1.29 Million | -138.99 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 128 Thousand | 69.11 Million | 8.05 Million | 5.92 Million | 8.1 Million |
| Other Financing Activities | 159 Thousand | -2000.00 | -545 Thousand | 4.14 Million | 4.94 Million | 8751.81 |
| Accounts receivables | 224 Thousand | 287 Thousand | -1.35 Million | -39 Thousand | -185.76 Thousand | -61.98 Thousand |
| Accounts payables | -217 Thousand | 927 Thousand | -4.74 Million | 2.54 Million | 791.1 Thousand | -99.91 Thousand |
| Inventory | -239 Thousand | -99 Thousand | 530 Thousand | -621 Thousand | 303.14 Thousand | -353.32 Thousand |
| Other working capital | 260 Thousand | 1.38 Million | 25.23 Million | -190 Thousand | 1.31 Million | 39.27 Thousand |
| Cash at beginning of period | 34.8 Million | 71.97 Million | 6.18 Million | 5.99 Million | 3.72 Million | 1.5 Million |
| Cash at end of period | 6.75 Million | 34.8 Million | 71.97 Million | 6.18 Million | 5.99 Million | 3.72 Million |
| Capital Expenditure | -9000.00 | -9000.00 | - | -2000.00 | -157.4 Thousand | -50.63 Thousand |
| Effect of forex changes on cash | - | - | - | 23 Thousand | -7070.00 | -26.69 Thousand |
| Net cash flow / Change in cash | -28.05 Million | -37.16 Million | 65.79 Million | 189 Thousand | 2.26 Million | 2.22 Million |
| Free Cash Flow | -16.31 Million | -16.92 Million | -105 Thousand | -11.93 Million | -7.21 Million | -6.5 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.21 Million | -5 Million | -5.78 Million | -3.54 Million | -19.47 Million | -4.31 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 442.00 | -79 Thousand | 416 Thousand | 451 Thousand | 2.8 Million | 808 Thousand |
| Change in working capital | -73 Thousand | -1.34 Million | 786 Thousand | -537 Thousand | 28 Thousand | -176 Thousand |
| Other non-cash items | 384 Thousand | 61 Thousand | 349 Thousand | 250 Thousand | 334 Thousand | 80 Thousand |
| Investing Cash Flow | 11.04 Million | 1.78 Million | 6.62 Million | -549 Thousand | -11.82 Million | 532 Thousand |
| Investments in PPE | - | - | - | 2000.00 | -9000.00 | -11 Thousand |
| Acquisitions | 875 Thousand | - | - | -240 Thousand | 319 Thousand | 559 Thousand |
| Investment purchases | - | -3.31 Million | -10.1 Million | -10.31 Million | -48.43 Million | -10.01 Million |
| Sales/Maturities of investments | 10.16 Million | 5.09 Million | 16.73 Million | 10 Million | 36.29 Million | 10 Million |
| Other Investing Activities | 11.04 Thousand | 1782.00 | 6622.00 | -551.00 | -11.81 Thousand | 543.00 |
| Financing Cash Flow | - | - | - | 159 Thousand | 80 Thousand | -1000.00 |
| Debt repayment | - | - | - | -1.00 | -79 Thousand | -1000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 159 Thousand | 159 Thousand | -1000.00 |
| Accounts receivables | 57 Thousand | -142 Thousand | 67 Thousand | -109 Thousand | 224 Thousand | -326 Thousand |
| Accounts payables | - | - | - | -9000.00 | -217 Thousand | -95 Thousand |
| Inventory | - | - | - | 109 Thousand | -239 Thousand | 59 Thousand |
| Other working capital | -130 Thousand | -1.2 Million | 719 Thousand | -528 Thousand | 260 Thousand | 186 Thousand |
| Cash at beginning of period | 4.14 Million | 8.79 Million | 6.75 Million | 10.52 Million | 34.8 Million | 13.6 Million |
| Cash at end of period | 11.33 Million | 4.14 Million | 8.79 Million | 6.75 Million | 6.75 Million | 10.52 Million |
| Capital Expenditure | - | - | - | 2000.00 | -9000.00 | -11 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 7.19 Million | -4.65 Million | 2.03 Million | -3.77 Million | -28.05 Million | -3.07 Million |
| Free Cash Flow | -3.84 Million | -6.43 Million | -4.58 Million | -3.38 Million | -16.31 Million | -3.61 Million |
NXGPF
BORT
ELGIEQUIP
CDSL
LEENEE
ONVC